Does TROSPIUM Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TROSPIUM (TROSPIUM CHLORIDE). This represents 0.6% of all adverse event reports for TROSPIUM.
5
Reports of Malignant neoplasm progression with TROSPIUM
0.6%
of all TROSPIUM reports
0
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TROSPIUM?
Of the 5 reports.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TROSPIUM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TROSPIUM Cause?
Drug ineffective (106)
Fall (84)
General physical health deterioration (84)
Urinary retention (83)
Oedema peripheral (71)
Dizziness (69)
Hyponatraemia (67)
Acute kidney injury (66)
Dry mouth (66)
Constipation (64)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TROSPIUM Alternatives Have Lower Malignant neoplasm progression Risk?
TROSPIUM vs TROSPIUM\XANOMELINE
TROSPIUM vs TRUVADA
TROSPIUM vs TRYPTOPHAN
TROSPIUM vs TUBERCULIN PURIFIED PROTEIN DERIVATIVE
TROSPIUM vs TUCATINIB